Back to MORGAN STANLEY MORGAN STANLEY

CGEMCGEM
Showing 8 of 9 quarters

Position history for MORGAN STANLEYMORGAN STANLEY's holdings in CULLINAN THERAPEUTICS INC

MORGAN STANLEY holds 629,035 shares of CGEM (CULLINAN THERAPEUTICS INC), worth $11.5M as of 2026-Q2. The position was increased (+6.7% shares). CGEM represents 0.0% of MORGAN STANLEY's portfolio.

Current Value

$11.5M

Current Shares

629,035

Total Value Change

+$182,476

Total Shares Change

-44,337

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
629,035
+6.7%
$11.5M0.0%$18.21
30
2026-Q1
Decreased
589,483
-23.1%
$8.4M0.0%$15.73
0
2025-Q4
Increased
766,934
+91.7%
$7.9M0.0%$9.92
43
2025-Q3
Increased
400,154
+65.3%
$2.4M0.0%$5.97
38
2025-Q2
Decreased
242,092
-49.8%
$1.8M0.0%$7.76
0
2025-Q1
Decreased
481,832
-24.5%
$3.6M0.0%$8.02
0
2024-Q4
Decreased
638,069
-5.2%
$7.8M0.0%$12.20
0
2024-Q3
Decreased
673,372
-19.7%
$11.3M0.0%$17.19
0

Other major holders of CGEM: BlackRock, Inc., BAUPOST GROUP LLC/MA, STATE STREET CORP, BlackRock Finance, Inc.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used